Publications by authors named "Meredith Ferrante"

Claim this Profile
T
Triazolopyridine ethers as potent, orally active mGlu positive allosteric modulators for treating schizophrenia.
Mendi A Higgins, Lawrence R Marcin, F Christopher Zusi, Robert Gentles, Min Ding, Meredith Ferrante

Bioorg Med Chem· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design and Synthesis of a New Series of 4-Heteroarylamino-1'-azaspiro[oxazole-5,3'-bicyclo[2.2.2]octanes as α7 Nicotinic Receptor Agonists. 1. Development of Pharmacophore and Early Structure-Activity Relationship.
James Cook, F Christopher Zusi, Ivar M McDonald, Dalton King, Matthew D Hill, Meredith Ferrante

J Med Chem· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evidence for Classical Cholinergic Toxicity Associated with Selective Activation of M1 Muscarinic Receptors.
Andrew Alt, Annapurna Pendri, Robert L Bertekap, Guo Li, Yulia Benitex, Meredith Ferrante

J Pharmacol Exp Ther· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of D1 Dopamine Receptor Positive Allosteric Modulators: Characterization of Pharmacology and Identification of Residues that Regulate Species Selectivity.
Martin A Lewis, Lisa Hunihan, John Watson, Robert G Gentles, Shuanghua Hu, Meredith Ferrante

J Pharmacol Exp Ther· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design, synthesis, and evaluation of phenylglycinols and phenyl amines as agonists of GPR88.
Carolyn D Dzierba, Yingzhi Bi, Bireshwar Dasgupta, Richard A Hartz, Vijay Ahuja, Meredith Ferrante

Bioorg Med Chem Lett· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The discovery of potent agonists for GPR88, an orphan GPCR, for the potential treatment of CNS disorders.
Yingzhi Bi, Carolyn D Dzierba, Cynthia Fink, Yudith Garcia, Michael Green, Meredith Ferrante

Bioorg Med Chem Lett· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of a novel series of quinolone α7 nicotinic acetylcholine receptor agonists.
Ivar M McDonald, Robert A Mate, F Christopher Zusi, Hong Huang, Debra J Post-Munson, Meredith A Ferrante

Bioorg Med Chem Lett· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation and optimization of compound solubilization and delivery methods in a two-tiered ion channel lead optimization triage.
Adam W Hendricson, Liz Gallagher, Michele Matchett, Meredith Ferrante, Steve Spence

Assay Drug Dev Technol· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design of an automated enhanced-throughput platform for functional characterization of positive allosteric modulator-induced leftward shifts in apparent agonist potency in vitro.
Adam Hendricson, Michele Matchett, Meredith Ferrante, Chris Ferrante, Ed Hunnicutt

J Lab Autom· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Best practices in compound management for preserving compound integrity and accurately providing samples for assays.
Sandra L Matson, Moneesh Chatterjee, David A Stock, John E Leet, Elizabeth A Dumas, Christian D Ferrante, Meredith A Ferrante

J Biomol Screen· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis